App-Quantinova.ai

Pediatric Cortical Vein Thrombosis: Frequency and Association With Venous Infarction

Amanda Kenny - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Radiosurgery Induces Novel Protein Changes on the Endothelium of Arteriovenous Malformations: Potential for Therapeutic Targets

Vivienne S Lee - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Superoxide dismutase

Systemic Heparin Use and Outcomes in Cardiac Arrest Patients Treated with Therapeutic Hypothermia without Coronary Intervention

Benjamin B Holmes - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Pulmonary Microvascular Thrombosis Enhances Extravasation via Myeloid Hypoxia-Inducible Factors

Cristina Branco-Price - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risks and Predictors of Ischemic/bleeding Complications in Cardiac Patients Undergoing Elective Non-cardiac Surgery - An Analysis of the Prague-14 Study

Ladislav Dusek - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Immobilized ApoA-I and High Density Lipoproteins are Anti-thrombotic and Inhibit Smooth Muscle Cell Attachment and Proliferation

Joanne T Tan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Ischemic Stroke in Atrial Fibrillation: 30-day Outcomes and Factors Associated with Severity

Jonathan Thigpen - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Role of Neutrophil Extracellular Traps in the Pathogenesis of Pulmonary Hypertension.

Lucie Duluc - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Elaszym

Distinct Vascular Effects of Celecoxib and Rofecoxib in vivo

Tilo Grosser - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prostacyclin

Coronary Endothelial Dysfunction Is Associated With Increased Risk of Venous Thromboembolism

Martin Reriani - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Acetylcholine

Development of an Antidote-Controlled RNA Probe for Molecular Thrombi Imaging

Bethany Powell Gray - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Risk Factors for Venous Thromboembolism (VTE) among Patients with Neurologic Disease and Leg Paresis: A Population-based Case-control Study.

Karen L. Andrews - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Factor XII Knockout or Knockdown in Rat Produces Robust Antithrombotic Efficacy With No Bleeding

Tian-Quan Cai - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Inhibition of Tissue Factor Reduces Thrombosis and Inflammation Without Increased Bleeding in a Mouse Model of Ischemic Stroke

Brandi Reeves - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Use of Eptifibatide in patients with ventricular assist devices and Bleeding outcomes

Sula Mazimba - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

eptifibatide

Bioengineering L-605 Cobalt Chromium Cardiovascular Stent Biomaterial With Plasma Activated Coating, for Proactive Biocompatibility

Steven G. Wise - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Effect of HDL on Platelet Apoptosis and Aggregation

Jing Du - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ApoA-I Suppresses Neointimal Hyperplasia Following Stent Deployment and Modulates Neointimal Cellular Phenotype

Joanne T Tan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Glucagon Like Peptide -1 Receptor Activation Does Not Affect Re-endothelialization But Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Non-diabetic Model of Arterial Injury

Robert Saxelin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

Platelet Specific Deletion of Opa-1 Reveals Gender Dimorphic Effects on Platelet Dysfunction and Thrombus Formation in Mice

Trevor P Fidler - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Hydrogen peroxide

Filters

7277 Abstracts